Phathom Pharmaceuticals (PHAT) Other Operating Expenses (2019)

Phathom Pharmaceuticals' (PHAT) quarterly Other Operating Expenses came in at $78.9 million in Q2 2019.

Phathom Pharmaceuticals (PHAT) Other Operating Expenses (2019) Analysis & Trends

Phathom Pharmaceuticals (PHAT) has 1 years of Other Operating Expenses data on file, last reported at $78.9 million in Q2 2019.

On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $78.9 million in Q2 2019; TTM through Mar 2020 was $78.9 million, a N/A change from a year earlier, with the FY2019 full-year figure at $78.9 million, changed N/A from the prior year.
Other Operating Expenses for Q2 2019 stood at $78.9 million.
Over the last five years, Other Operating Expenses for PHAT reached as high as $78.9 million in Q2 2019 and fell as low as $78.9 million in Q2 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Phathom Pharmaceuticals	951.79 Mn	768.02 Mn	46.31 Mn

Download Data

Date	Value
Jun 30, 2019	78.90 Mn